PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
about
The HTLV-1 Tax interactomeFrom bytes to bedside: data integration and computational biology for translational cancer researchSilencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeletonSAM68: Signal Transduction and RNA Metabolism in Human CancerMice lacking pten in osteoblasts have improved intramembranous and late endochondral fracture healingCirculating tumor cells versus circulating tumor DNA in lung cancer-which one will win?Akt1 enhances CA916798 expression through mTOR pathwayDifferential effects of an O-GlcNAcase inhibitor on tau phosphorylationNanostructured scaffold as a determinant of stem cell fateIncreased Sensitivity to Noise-Induced Hearing Loss by Blockade of Endogenous PI3K/Akt Signaling.PTEN attenuates PIP3/Akt signaling in the cochlea of the aging CBA/J mouse.Systemic therapy for advanced hepatocellular carcinoma: an update.PAR1- and PAR2-induced innate immune markers are negatively regulated by PI3K/Akt signaling pathway in oral keratinocytes.Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells.Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenesExpression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication.Intrinsic differences between oral and skin keratinocytesmiRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisBiphasic modulation of paracellular claudin-5 expression in mouse brain endothelial cells is mediated through the phosphoinositide-3-kinase/AKT pathwayGenetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instabilityPhiladelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosomeOpposing oncogenic activities of small DNA tumor virus transforming proteins.InAKTivation of insulin/IGF-1 signaling by dephosphorylation.Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.All-Trans Retinoic Acid-Induced Deficiency of the Wnt/β-Catenin Pathway Enhances Hepatic Carcinoma Stem Cell Differentiation.Attenuation of age-related changes in FOXO3a activity and the PI3K/Akt pathway by short-term feeding of ferulate.Simvastatin reverses cardiomyocyte hypertrophy via the upregulation of phosphatase and tensin homolog expression.ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium.Hepatocellular carcinoma: focus on different aspects of managementCancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerabilityAloe vera non-decolorized whole leaf extract-induced large intestinal tumors in F344 rats share similar molecular pathways with human sporadic colorectal tumors.Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma.Akt1 is critical for acute inflammation and histamine-mediated vascular leakageWWP2 is an E3 ubiquitin ligase for PTEN.Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.PTEN in DNA damage repair.
P2860
Q21093224-71419277-301C-438A-B6D4-2FBB683C77BCQ21145672-C053409D-63CA-4941-BF6C-E43E490F2109Q24308073-0839600D-D1A6-429E-B418-3F248081D49AQ26798149-B60572D7-B4F5-4B85-B97C-6E724E74C8FAQ27319993-CD59BE63-BE2A-452D-9FA9-D7BE81CF12CAQ28077340-086C1122-6C44-4729-8B1A-A93AE65BF93DQ28487802-0BDFE054-8F6D-45FA-B74D-4DA894A6E3C4Q28730451-D95360FF-214D-4063-8518-B4FA77D7B476Q28818316-2367AAE2-3258-4E1B-A9F3-8F55F2D33B3EQ30382377-3954A4F4-127B-4911-8399-8CD6B15162CFQ30475282-74D3ADB8-25C4-4869-8973-206ECF4F8F50Q33593213-61336B2F-3EEC-41FF-8D70-15528C203C33Q33732124-77F0BECB-CA31-4D9F-99C5-753CE4A02F7EQ34031478-9E7A3B11-F699-4928-BA11-1779E92F9DD5Q34037679-208F1D57-90D3-45B8-BA9E-E6E93D051299Q34050186-996DF9D5-6EFD-4B44-9035-D7B6CD051098Q34092016-0EC32CDF-5139-44DA-8309-5D827BB1CABCQ34149597-D3753A2C-7195-4DDA-8DE4-4991D09A1DCFQ34311399-6545915C-6C45-4687-9B26-996560BA771EQ34493341-C54D1052-4C96-4207-8BC8-839AF2635C17Q34573889-DADAF34D-D3C0-436E-8BF4-1FEC56C3CC0CQ34768295-F7207A4A-74BF-4155-8BC1-ECBB0B20ACA9Q34975366-2BADB2D3-F300-4BB1-8615-38421F8D697AQ34985200-0BB8D7A4-724B-4726-8D9A-D034BBD44188Q35030359-AAE03F58-242D-4740-881D-A25CB2C969C4Q35080706-ED85A15E-3AA7-404A-8B1A-D1DFAED56ED3Q35157985-EA572BBA-BD25-4B00-B2AB-D9987BEE6C7DQ35720774-82B9D5F6-6810-4FE7-9929-D60784CB54CDQ35842005-DAD326D6-5BDC-428D-8108-4CF1FB449534Q35853622-5A3BB14A-03C0-409B-9045-FF909464AD06Q35870246-F22DAEED-0F2E-456D-9EA6-4558A3CEF697Q35912379-1E381722-0AD6-4D26-B695-287DA8F94A51Q35986436-9440AD88-7D1A-49F4-B62E-17586E4186B1Q36632860-5E37ED52-9EAF-46A6-AF23-8C66F1872B9FQ37013930-70AE13AA-3B54-4BF7-A00F-DD6FDE34140AQ37254508-E90CE2B4-189D-4965-AA17-2F5DF4759973Q37321172-A9ABA4FB-AF1B-4AF3-8252-C1009047CCBCQ37588182-13A6462C-4517-417C-9A6D-0FFB38700A85Q37594844-89F7ADDE-D2CF-4C82-A0E3-90A8BA8081C0Q37977769-150A55D7-8EF7-4F41-A000-F4D3ACBB039D
P2860
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
@ast
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
@en
type
label
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
@ast
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
@en
prefLabel
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
@ast
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
@en
P1476
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
@en
P2093
William R Sellers
P304
P577
2003-01-01T00:00:00Z